$3.93
0[0.00%]
Last update: 9:36AM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
| Open- | Close- |
| Vol / Avg.0 / 634.000 | Mkt Cap207.000M |
| Day Range- - - | 52 Wk Range3.930 - 6.868 |
Hansa Biopharma Stock (OTC:HNSBF), Key Statistics
Hansa Biopharma Stock (OTC: HNSBF) analysis, key statistics.
Valuation Measures
Enterprise Value
150.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.53
Price / Book (mrq)
12.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-35%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.31
Tangible Book value per share
0.15
Total Liabilities (Quarterly)
1.2B
Total Assets
1.4B
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
48.94%
Net Margin
-685.32%
EBIT Margin
-623.3%
EBITDA Margin
-623.3%
Operating Margin
-623.3%
Hansa Biopharma Stock (OTC:HNSBF), Key Statistics
Hansa Biopharma Stock (OTC: HNSBF) analysis, key statistics.
Valuation Measures
Enterprise Value
150.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.53
Price / Book (mrq)
12.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-35%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.31
Tangible Book value per share
0.15
Total Liabilities (Quarterly)
1.2B
Total Assets
1.4B
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
48.94%
Net Margin
-685.32%
EBIT Margin
-623.3%
EBITDA Margin
-623.3%
Operating Margin
-623.3%
Hansa Biopharma Stock (OTC:HNSBF), Key Statistics
Hansa Biopharma Stock (OTC: HNSBF) analysis, key statistics.
Valuation Measures
Enterprise Value
150.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.53
Price / Book (mrq)
12.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-35%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.31
Tangible Book value per share
0.15
Total Liabilities (Quarterly)
1.2B
Total Assets
1.4B
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
48.94%
Net Margin
-685.32%
EBIT Margin
-623.3%
EBITDA Margin
-623.3%
Operating Margin
-623.3%
Hansa Biopharma Stock (OTC:HNSBF), Key Statistics
Hansa Biopharma Stock (OTC: HNSBF) analysis, key statistics.
Valuation Measures
Enterprise Value
150.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.53
Price / Book (mrq)
12.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-35%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.31
Tangible Book value per share
0.15
Total Liabilities (Quarterly)
1.2B
Total Assets
1.4B
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
48.94%
Net Margin
-685.32%
EBIT Margin
-623.3%
EBITDA Margin
-623.3%
Operating Margin
-623.3%
Hansa Biopharma Stock (OTC:HNSBF), Key Statistics
Hansa Biopharma Stock (OTC: HNSBF) analysis, key statistics.
Valuation Measures
Enterprise Value
150.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.53
Price / Book (mrq)
12.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-35%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.31
Tangible Book value per share
0.15
Total Liabilities (Quarterly)
1.2B
Total Assets
1.4B
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
48.94%
Net Margin
-685.32%
EBIT Margin
-623.3%
EBITDA Margin
-623.3%
Operating Margin
-623.3%
Hansa Biopharma Stock (OTC:HNSBF), Key Statistics
Hansa Biopharma Stock (OTC: HNSBF) analysis, key statistics.
Valuation Measures
Enterprise Value
150.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.53
Price / Book (mrq)
12.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-35%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.31
Tangible Book value per share
0.15
Total Liabilities (Quarterly)
1.2B
Total Assets
1.4B
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
48.94%
Net Margin
-685.32%
EBIT Margin
-623.3%
EBITDA Margin
-623.3%
Operating Margin
-623.3%
Hansa Biopharma Stock (OTC:HNSBF), Key Statistics
Hansa Biopharma Stock (OTC: HNSBF) analysis, key statistics.
Valuation Measures
Enterprise Value
150.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.53
Price / Book (mrq)
12.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-35%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.31
Tangible Book value per share
0.15
Total Liabilities (Quarterly)
1.2B
Total Assets
1.4B
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
48.94%
Net Margin
-685.32%
EBIT Margin
-623.3%
EBITDA Margin
-623.3%
Operating Margin
-623.3%
Hansa Biopharma Stock (OTC:HNSBF), Key Statistics
Hansa Biopharma Stock (OTC: HNSBF) analysis, key statistics.
Valuation Measures
Enterprise Value
150.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.53
Price / Book (mrq)
12.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-35%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.31
Tangible Book value per share
0.15
Total Liabilities (Quarterly)
1.2B
Total Assets
1.4B
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
48.94%
Net Margin
-685.32%
EBIT Margin
-623.3%
EBITDA Margin
-623.3%
Operating Margin
-623.3%
Hansa Biopharma Stock (OTC:HNSBF), Key Statistics
Hansa Biopharma Stock (OTC: HNSBF) analysis, key statistics.
Valuation Measures
Enterprise Value
150.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.53
Price / Book (mrq)
12.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-35%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.31
Tangible Book value per share
0.15
Total Liabilities (Quarterly)
1.2B
Total Assets
1.4B
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
48.94%
Net Margin
-685.32%
EBIT Margin
-623.3%
EBITDA Margin
-623.3%
Operating Margin
-623.3%